Market Access & Patient Advocacy Subcommittee

Charter

The Market Access & Patient Advocacy Subcommittee strives to:

  • Educate the cell therapy industry on pre-commercialization reimbursement considerations.
  • Identify and recruit leaders in industry who have late-stage development products and have addressed regulatory and manufacturing hurdles.

Projects and Objectives

  • Describe reimbursement policies on a regional basis to include the UK, Australia and USA.
  • Organize an ISCT webinar on reimbursement considerations.



 

Committee Chair

Dawn Driscoll, PhD, MBA
Co-Chair
Cell Therapies PTY
Melbourne, Australia
Gerhard Bauer, PhD
Co-Chair

UC Davis
Sacramento, CA, United States

 

Committee Members

Derek Hei, PhD
BlueRock Therapeutics
Cambridge, MA, United States


 

© 2018 ISCT. All rights reserved. 
ISCT, and the ISCT logo are registered service marks of the International Society for Cellular Therapy.
The BEACON and lighthouse logo is a service mark of the International Society for Cellular Therapy.